Changes in antigen expression on differentiating HL60 cells treated with dimethylsulphoxide, all-trans retinoic acid, α1,25-dihydroxyvitamin D3 or 12-O-tetradecanoyl phorbol-13-acetate

被引:76
作者
Trayner, ID
Bustorff, T
Etches, AE
Mufti, GJ
Foss, Y
Farzaneh, F
机构
[1] Univ London Kings Coll, Sch Med & Dent, Dept Mol Med, London SE5 9NU, England
[2] Univ London Kings Coll, Sch Med & Dent, Dept Haematol, London SE5 9RS, England
关键词
leukemic myeloid cell differentiation; antigen expression; HL60; cells;
D O I
10.1016/S0145-2126(98)00041-1
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We describe changes in antigen expression on HL60 cells with differentiation into granulocytes induced by all-trans retinoic acid (ATRA) or dimethylsulphoxide (DMSO), into monocytes by alpha 1,25-dihydroxyvitamin D-3 (D-3), or into macrophages by 12-O-tetradecanoyl phorbol-13-acetate (TPA). Undifferentiated cells expressed CD13, CD14 (at a low level), CD15, CDwl7, CD32, CD33, CD49e, CD63, CD64, CDw65, CD71 and CD87 antigens and bound the unclustered mAb D171 and Mo5. Differentiated and undifferentiated cells were negative for CD16, CD34, CD61, CDB6abcde, CD68, CD88, CDw90 and CD93. Four panels of markers were identified whose expression changes significantly following differentiation. CD15, CD49e, CD63, CDw65, CD71 and mAb D171 and IGR-2,1A6 for DMSO; CD13, CD15, CDwl7, CD49e, CD63, CDw65, CD71, CD87, CDw92 and mAb D171 and IGR-2,1A6 for ATRA; CD14, CD31, CD35, CD71, CD87, CDw92 and mAb D171 and BRIC18 for D-3; CDw12, CD13, CD15, CD31, CD35, CD49e; CD71, CD87, CDw92 and mAb D171 for TPA. These will be useful for analyzing the pathways that regulate differentiation, whether the observed changes are consequences of differentiation or more direct effects of the inducers. HL60 cells provide a model for investigating the regulation of these antigens. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:537 / 547
页数:11
相关论文
共 42 条
[1]  
Ball ED, 1995, LEUCOCYTE TYPING, P790
[2]   RELATIONSHIPS BETWEEN THE CELL-CYCLE AND THE EXPRESSION OF C-MYC AND TRANSFERRIN RECEPTOR GENES DURING INDUCED MYELOID DIFFERENTIATION [J].
BARKER, KA ;
NEWBURGER, PE .
EXPERIMENTAL CELL RESEARCH, 1990, 186 (01) :1-5
[3]   IMMUNOHISTOLOGICAL PATTERNS OF MYELOID ANTIGENS - TISSUE DISTRIBUTION OF CD13, CD14, CD16, CD31, CD36, CD65, CD66 AND CD67 [J].
BORDESSOULE, D ;
JONES, M ;
GATTER, KC ;
MASON, DY .
BRITISH JOURNAL OF HAEMATOLOGY, 1993, 83 (03) :370-383
[4]   INDUCTION OF DIFFERENTIATION OF THE HUMAN PROMYELOCYTIC LEUKEMIA-CELL LINE (HL-60) BY RETINOIC ACID [J].
BREITMAN, TR ;
SELONICK, SE ;
COLLINS, SJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1980, 77 (05) :2936-2940
[5]  
BUDDE P, 1995, LEUKOCYTE TYPING, V5, P806
[6]  
BUNCE CM, 1995, LEUKEMIA, V9, P410
[7]   CONTINUOUS GROWTH AND DIFFERENTIATION OF HUMAN MYELOID LEUKEMIC-CELLS IN SUSPENSION CULTURE [J].
COLLINS, SJ ;
GALLO, RC ;
GALLAGHER, RE .
NATURE, 1977, 270 (5635) :347-349
[8]   NORMAL FUNCTIONAL-CHARACTERISTICS OF CULTURED HUMAN PROMYELOCYTIC LEUKEMIA-CELLS (HL-60) AFTER INDUCTION OF DIFFERENTIATION BY DIMETHYLSULFOXIDE [J].
COLLINS, SJ ;
RUSCETTI, FW ;
GALLAGHER, RE ;
GALLO, RC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 149 (04) :969-974
[9]  
COLLINS SJ, 1987, BLOOD, V70, P1233
[10]  
CORDELL JL, 1995, LEUKOCYTE TYPING, V5, P925